X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (25628) 25628
Book Review (3287) 3287
Publication (1540) 1540
Newsletter (230) 230
Newspaper Article (91) 91
Book Chapter (53) 53
Conference Proceeding (48) 48
Magazine Article (46) 46
Dissertation (9) 9
Transcript (8) 8
Book / eBook (3) 3
Trade Publication Article (3) 3
Presentation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (22747) 22747
humans (18597) 18597
male (11927) 11927
dexamethasone (11583) 11583
female (11560) 11560
dexamethasone - therapeutic use (10117) 10117
adult (6938) 6938
middle aged (6856) 6856
animals (6280) 6280
dexamethasone - administration & dosage (5269) 5269
aged (4868) 4868
oncology (3684) 3684
treatment outcome (3629) 3629
dexamethasone - pharmacology (3395) 3395
antineoplastic combined chemotherapy protocols - therapeutic use (3172) 3172
abridged index medicus (3073) 3073
pharmacology & pharmacy (2869) 2869
hematology (2825) 2825
rats (2386) 2386
adolescent (2357) 2357
glucocorticoids - therapeutic use (2297) 2297
multiple myeloma - drug therapy (2266) 2266
corticosteroids (2153) 2153
multiple myeloma (2120) 2120
anti-inflammatory agents - therapeutic use (2112) 2112
therapy (2087) 2087
steroids (2044) 2044
mice (2026) 2026
child (1921) 1921
drug therapy, combination (1875) 1875
chemotherapy (1873) 1873
care and treatment (1784) 1784
bortezomib (1692) 1692
analysis (1674) 1674
dexamethasone - adverse effects (1602) 1602
cancer (1563) 1563
time factors (1514) 1514
glucocorticoids (1486) 1486
aged, 80 and over (1440) 1440
inflammation (1425) 1425
research (1378) 1378
retrospective studies (1364) 1364
pediatrics (1348) 1348
dose-response relationship, drug (1315) 1315
drug therapy (1314) 1314
medicine & public health (1300) 1300
prospective studies (1277) 1277
surgery (1245) 1245
child, preschool (1243) 1243
expression (1239) 1239
health aspects (1227) 1227
infant, newborn (1160) 1160
antineoplastic combined chemotherapy protocols - adverse effects (1135) 1135
double-blind method (1132) 1132
immunology (1121) 1121
disease models, animal (1114) 1114
pregnancy (1094) 1094
prognosis (1085) 1085
follow-up studies (1083) 1083
antineoplastic agents - therapeutic use (1077) 1077
glucocorticoids - administration & dosage (1062) 1062
medicine, general & internal (1039) 1039
children (1030) 1030
infant (1028) 1028
neurosciences (995) 995
antiemetics - therapeutic use (992) 992
glucocorticoids - pharmacology (989) 989
prevention (963) 963
risk factors (963) 963
ophthalmology (960) 960
clinical neurology (944) 944
double-blind (929) 929
combined modality therapy (928) 928
survival (920) 920
drug administration schedule (919) 919
recurrence (916) 916
stem-cell transplantation (916) 916
dosage and administration (915) 915
thalidomide (900) 900
lenalidomide (873) 873
thalidomide - analogs & derivatives (858) 858
cyclophosphamide - administration & dosage (857) 857
doxorubicin - administration & dosage (857) 857
endocrinology & metabolism (852) 852
vincristine - administration & dosage (849) 849
cells (847) 847
antineoplastic agents - adverse effects (841) 841
young adult (840) 840
hydrocortisone - blood (830) 830
transplantation (822) 822
anti-inflammatory agents - administration & dosage (810) 810
article (806) 806
cells, cultured (796) 796
apoptosis (786) 786
rats, sprague-dawley (773) 773
remission induction (772) 772
trial (769) 769
thalidomide - administration & dosage (763) 763
diagnosis (735) 735
efficacy (723) 723
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (23855) 23855
German (502) 502
Japanese (336) 336
French (323) 323
Chinese (252) 252
Spanish (212) 212
Russian (155) 155
Polish (91) 91
Italian (74) 74
Portuguese (45) 45
Czech (42) 42
Dutch (31) 31
Hungarian (20) 20
Danish (13) 13
Turkish (12) 12
Romanian (11) 11
Bulgarian (9) 9
Croatian (9) 9
Norwegian (8) 8
Hebrew (7) 7
Serbian (7) 7
Finnish (6) 6
Korean (6) 6
Swedish (6) 6
Ukrainian (5) 5
Slovak (3) 3
Slovenian (2) 2
Indonesian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


European Journal of Pharmaceutics and Biopharmaceutics, ISSN 0939-6411, 07/2017, Volume 116, pp. 1 - 3
Journal Article
Journal Article
Cancer Cell, ISSN 1535-6108, 09/2012, Volume 22, Issue 3, pp. 345 - 358
Bortezomib therapy has proven successful for the treatment of relapsed/refractory, relapsed, and newly diagnosed multiple myeloma (MM); however, dose-limiting... 
DEUBIQUITINATING ENZYME | INACTIVATION | PROTEIN | THERAPY | ONCOLOGY | MDM2 | DEGRADATION | MECHANISMS | HAUSP | CANCER | P53 REGULATION | CELL BIOLOGY | Thiophenes - therapeutic use | Apoptosis - drug effects | Humans | Molecular Sequence Data | Antineoplastic Agents - therapeutic use | Pyrazines - therapeutic use | Thalidomide - pharmacology | Boronic Acids - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Protease Inhibitors - pharmacology | Thalidomide - analogs & derivatives | Multiple Myeloma - drug therapy | Dexamethasone - pharmacology | Antineoplastic Agents - pharmacology | Drug Therapy, Combination | Multiple Myeloma - enzymology | Protease Inhibitors - therapeutic use | Proto-Oncogene Proteins c-mdm2 - metabolism | Ubiquitin Thiolesterase - antagonists & inhibitors | Bortezomib | Cyclin-Dependent Kinase Inhibitor p21 - antagonists & inhibitors | Thiophenes - pharmacology | Random Allocation | Mice, SCID | Ubiquitin Thiolesterase - genetics | Xenograft Model Antitumor Assays | Dexamethasone - therapeutic use | Multiple Myeloma - pathology | Animals | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Neovascularization, Pathologic - drug therapy | Cell Line, Tumor | Mice | Thalidomide - therapeutic use | Pyrazines - pharmacology | Ubiquitin-Specific Peptidase 7 | Boronic Acids - pharmacology | Drug Resistance, Neoplasm - drug effects | Medical colleges | Dexamethasone | Proteases | Analysis | Multiple myeloma | Lymphomas | Apoptosis | Index Medicus
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 07/2017, Volume 35, Issue 20, pp. 2260 - 2267
Journal Article
Cancer, ISSN 0008-543X, 12/2015, Volume 121, Issue 23, pp. 4158 - 4164
Durable remissions and long‐term survival can be achieved with a combination of chemotherapy and dasatinib in patients with Philadelphia chromosome‐positive... 
dasatinib | acute lymphoblastic leukemia | chemotherapy | combination | Philadelphia chromosome | ADULT PATIENTS | ACUTE LYMPHOCYTIC-LEUKEMIA | REGIMEN | HYPER-CVAD | PONATINIB | THERAPY | ONCOLOGY | IMATINIB | MRD | Doxorubicin - therapeutic use | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Follow-Up Studies | Cytarabine - therapeutic use | Humans | Middle Aged | Male | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Methotrexate - therapeutic use | Cyclophosphamide - therapeutic use | Neoplasm, Residual | Young Adult | Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Aged, 80 and over | Vincristine - administration & dosage | Adult | Female | Philadelphia Chromosome | Doxorubicin - administration & dosage | Dexamethasone - administration & dosage | Dasatinib - therapeutic use | Treatment Outcome | Cytarabine - administration & dosage | Precursor Cell Lymphoblastic Leukemia-Lymphoma - genetics | Dexamethasone - therapeutic use | Dasatinib - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Survival Analysis | Vincristine - therapeutic use | Methotrexate - administration & dosage | Aged | Dasatinib | Chemotherapy | Usage | Care and treatment | Lymphocytic leukemia | Stem cells | Dosage and administration | Transplantation | Diagnosis | Cancer | Index Medicus | Abridged Index Medicus
Journal Article
PLoS ONE, ISSN 1932-6203, 06/2018, Volume 13, Issue 6, pp. e0198184 - e0198184
Background Many patients with immune thrombocytopenia (ITP) may require special attention and long-term treatment. Little is known on the efficacy and... 
AUTOIMMUNE THROMBOCYTOPENIA | TREATMENT OPTIONS | ADULT PATIENTS | INTRAVENOUS GAMMA-GLOBULIN | MANAGEMENT | ANTI-D | MEDICAL THERAPY | SAFETY | PURPURA | ROMIPLOSTIM | MULTIDISCIPLINARY SCIENCES | Prednisolone - adverse effects | Azathioprine - therapeutic use | Pyrazoles - therapeutic use | Benzoates - therapeutic use | Recombinant Fusion Proteins - adverse effects | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Immunoglobulins, Intravenous - adverse effects | Child, Preschool | Dexamethasone - adverse effects | Male | Dapsone - therapeutic use | Purpura, Thrombocytopenic, Idiopathic - drug therapy | Receptors, Fc - therapeutic use | Splenectomy | Young Adult | Aged, 80 and over | Child | Rituximab - adverse effects | Purpura, Thrombocytopenic, Idiopathic - surgery | Combined Modality Therapy | Remission Induction | Cyclosporine - therapeutic use | Dexamethasone - therapeutic use | Immunoglobulins, Intravenous - therapeutic use | Rho(D) Immune Globulin - adverse effects | Cyclosporine - adverse effects | Adolescent | Rho(D) Immune Globulin - therapeutic use | Dapsone - adverse effects | Benzoates - adverse effects | Recombinant Fusion Proteins - therapeutic use | Thrombopoietin - therapeutic use | Purpura, Thrombocytopenic, Idiopathic - therapy | Rituximab - therapeutic use | Adult | Female | Prednisolone - therapeutic use | Retrospective Studies | Drug Therapy, Combination | Drug Resistance | Pyrazoles - adverse effects | Hydrazines - therapeutic use | Treatment Outcome | Thrombopoietin - adverse effects | Immunosuppressive Agents - adverse effects | Aged | Azathioprine - adverse effects | Hydrazines - adverse effects | Thrombocytopenic purpura | Clinical trials | Treatment outcome | Care and treatment | Analysis | Drugs | Thrombocytopenia | Therapy | Immunoglobulins | Dexamethasone | Intravenous administration | Medical treatment | Medical services | Patients | Immunosuppressive agents | Bleeding | Medicine | Remission | Clinical medicine | Azathioprine | Drug dosages | Prednisolone | Index Medicus
Journal Article
Lancet, The, ISSN 0140-6736, 2017, Volume 389, Issue 10068, pp. 519 - 527
Journal Article
Blood, ISSN 0006-4971, 08/2012, Volume 120, Issue 8, pp. 1589 - 1596
The Spanish Myeloma Group conducted a trial to compare bortezomib/thalidomide/dexamethasone (VTD) versus thalidomide/dexamethasone (TD) versus vincristine,... 
TRIAL | SURVIVAL | PLUS DEXAMETHASONE | COMPLETE REMISSION | HIGH-DOSE THERAPY | COMPLETE RESPONSE | DOXORUBICIN | PERIPHERAL NEUROPATHY | CONTINUED STANDARD CHEMOTHERAPY | STEM-CELL TRANSPLANTATION | HEMATOLOGY | Boronic Acids - toxicity | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Middle Aged | Pyrazines - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Boronic Acids - adverse effects | Dexamethasone - adverse effects | Dexamethasone - toxicity | Induction Chemotherapy | Male | Transplantation, Autologous | Antineoplastic Agents - therapeutic use | Pyrazines - therapeutic use | Antineoplastic Agents - administration & dosage | Boronic Acids - therapeutic use | Antineoplastic Agents - toxicity | Multiple Myeloma - therapy | Pyrazines - toxicity | Antineoplastic Agents - adverse effects | Female | Boronic Acids - administration & dosage | Thalidomide - adverse effects | Bortezomib | Dexamethasone - administration & dosage | Multiple Myeloma - diagnosis | Thalidomide - administration & dosage | Thalidomide - toxicity | Antineoplastic Combined Chemotherapy Protocols - toxicity | Disease-Free Survival | Dexamethasone - therapeutic use | Multiple Myeloma - pathology | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Pyrazines - adverse effects | Stem Cells - drug effects | Stem Cells - pathology | Aged | Hematopoietic Stem Cell Transplantation - methods | Thalidomide - therapeutic use | Index Medicus | Abridged Index Medicus
Journal Article
American Journal of Hematology, ISSN 0361-8609, 11/2015, Volume 90, Issue 11, pp. 981 - 985
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 08/2012, Volume 30, Issue 24, pp. 2946 - 2955
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 16, pp. 1617 - 1629